These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 233155)

  • 1. Scopolamine-induced muscarinic supersensitivity in normal man: changes in sleep.
    Sitaram N; Moore AM; Gillin JC
    Psychiatry Res; 1979 Jul; 1(1):9-16. PubMed ID: 233155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic supersensitivity: a possible model for the sleep disturbance of primary depression?
    Gillin JC; Sitaram N; Duncan WC
    Psychiatry Res; 1979 Jul; 1(1):17-22. PubMed ID: 233154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and resetting of REM sleep rhythm in normal man by arecholine: blockade by scopolamine.
    Sitaram N; Moore AM; Gillin JC
    Sleep; 1978 Sep; 1(1):83-90. PubMed ID: 227024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholinergic REM induction test with RS 86 after scopolamine pretreatment in healthy subjects.
    Riemann D; Hohagen F; Fleckenstein P; Schredl M; Berger M
    Psychiatry Res; 1991 Sep; 38(3):247-60. PubMed ID: 1754637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of tolerance after repeated administration of a selective muscarinic M1 antagonist biperiden in healthy human volunteers.
    Salin-Pascual RJ; Granados-Fuentes D; Galicia-Polo L; Nieves E; Gillin JC
    Biol Psychiatry; 1993 Feb; 33(3):188-93. PubMed ID: 8448266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring cholinergic sensitivity: I. Arecoline effects in bipolar patients.
    Nurnberger J; Berrettini W; Mendelson W; Sack D; Gershon ES
    Biol Psychiatry; 1989 Mar; 25(5):610-7. PubMed ID: 2920194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal scopolamine alters phasic REM activity in normal young adults.
    Kim EJ; Jeong DU
    Sleep; 1999 Jun; 22(4):515-20. PubMed ID: 10389227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic REM sleep induction by arecoline in normal subjects: relation to thyroid function.
    Keshavan M; Dubé S; Grabowski J; Sitaram N
    Psychiatry Res; 1988 Jun; 24(3):333-6. PubMed ID: 3406243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects.
    Poland RE; McCracken JT; Lutchmansingh P; Lesser IM; Tondo L; Edwards C; Boone KB; Lin KM
    Biol Psychiatry; 1997 May; 41(9):929-38. PubMed ID: 9110098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring cholinergic sensitivity: II. Arecoline effects on metabolic activity in pontine regions of rat brain.
    Soncrant TT; Nurnberger J
    Biol Psychiatry; 1989 Mar; 25(5):618-25. PubMed ID: 2920195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of scopolamine on nocturnal cortisol secretion, sleep architecture, and REM latency in normal volunteers: relation to sleep and cortisol abnormalities in depression.
    Poland RE; Tondo L; Rubin RT; Trelease RB; Lesser IM
    Biol Psychiatry; 1989 Feb; 25(4):403-12. PubMed ID: 2930809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related effects of scopolamine on REM sleep regulation in normal control subjects: relationship to sleep abnormalities in depression.
    Rao U; Lutchmansingh P; Poland RE
    Neuropsychopharmacology; 1999 Dec; 21(6):723-30. PubMed ID: 10633478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cholinergic rapid eye movement induction test with arecoline in depression.
    Gillin JC; Sutton L; Ruiz C; Kelsoe J; Dupont RM; Darko D; Risch SC; Golshan S; Janowsky D
    Arch Gen Psychiatry; 1991 Mar; 48(3):264-70. PubMed ID: 1996921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid-eye movement sleep and muscarinic receptor binding in rats are augmented during withdrawal from chronic scopolamine treatment.
    Sutin EL; Shiromani PJ; Kelsoe JR; Storch FI; Gillin JC
    Life Sci; 1986 Dec; 39(25):2419-27. PubMed ID: 3796202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist.
    Sitaram N; Moore AM; Gillin JC
    Nature; 1978 Aug; 274(5670):490-2. PubMed ID: 209333
    [No Abstract]   [Full Text] [Related]  

  • 16. REM sleep and cortisol responses to scopolamine during depression and remission in women.
    Rao U; Lin KM; Schramm P; Poland RE
    Int J Neuropsychopharmacol; 2004 Sep; 7(3):265-74. PubMed ID: 15132761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic REM sleep induction response correlation with endogenous major depressive subtype.
    Jones D; Kelwala S; Bell J; Dube S; Jackson E; Sitaram N
    Psychiatry Res; 1985 Feb; 14(2):99-110. PubMed ID: 3857656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A twin study of cholinergic REM induction.
    Nurnberger J; Sitaram N; Gershon ES; Gillin JC
    Biol Psychiatry; 1983 Oct; 18(10):1161-5. PubMed ID: 6652156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose dependent inhibition of REM sleep in normal volunteers by biperiden, a muscarinic antagonist.
    Gillin JC; Sutton L; Ruiz C; Golshan S; Hirsch S; Warmann C; Shiromani P
    Biol Psychiatry; 1991 Jul; 30(2):151-6. PubMed ID: 1912107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and use of pharmacological probes of the CNS in man: evidence of cholinergic abnormality in primary affective illness.
    Sitaram N; Gillin JC
    Biol Psychiatry; 1980 Dec; 15(6):925-55. PubMed ID: 7459412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.